ADRD-specific diagnosis intensity varies most for Black, Hispanic, and youngest subgroups
MONDAY, Aug. 19, 2024 (HealthDay News) — The rate of new Alzheimer disease and related dementias (ADRD) diagnoses varies across the United States, according to a study published online Aug. 16 in Alzheimer”s & Dementia.
Julie P.W. Bynum, M.D., M.P.H., from the University of Michigan Medical School in Ann Arbor, and colleagues used Medicare claims for a cohort of older adults across hospital referral regions (HRRs) to measure geographic variation in diagnosed cases of ADRD. ADRD-specific regional diagnosis intensity was measured as the ratio of expected new ADRD cases based on population demographics, risk factors, and practice intensity compared to observed cases.
The researchers found that across HRRs, the crude new ADRD diagnosis rate ranged from 1.7 to 5.4 per 100. The intensity of ADRD-specific diagnosis varied from 0.69 to 1.47 and varied most for Black, Hispanic, and the youngest (ages 66 to 74 years) subgroups. ADRD diagnosis intensity was associated with a twofold difference in receiving an ADRD diagnosis across all subgroups.
“These findings raise important questions regarding the degree to which differences in access and health care practices may drive excess variability in ADRD detection,” the authors write.
Voice Disorders Linked to Elevated Risk for Incident Cognitive Decline 
Dementia, Stroke Risk Elevated for Those With Severe Mental Illness 
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia 
Brain Abnormalities Identified in Children at Risk for Schizophrenia 
Exercise Link to Dementia Varies by Physical Activity Domain 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
.jpg)